Drugs@FDA document
ATROVENT Review · NDA 020394 SUPPL-4
Drugs@FDA document · BOEHRINGER INGELHEIM · Oct 27, 2000
Key facts
| Drug name | ATROVENT |
|---|---|
| Document type | Review |
| Application | NDA020394 |
| Submission | SUPPL-4 |
| Company | BOEHRINGER INGELHEIM |
| Document date | Oct 27, 2000 |
At a glance
- Efficacy-New Indication Document categories
- 1–9 Documents for this application
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About Drugs@FDA documents
Drugs@FDA posts the letters, labels, reviews and other documents behind each drug application and supplement. Orca1 indexes every document's full text and flags complete response letters.
Source: U.S. Food and Drug Administration (FDA), Drugs@FDA application documents · Source date: